Tandem Labs
Kristen Thomas, BS, CPhT, possesses extensive experience in quality assurance and pharmacy operations. Currently serving as a Quality Assurance Auditor at Tandem Labs since 2015, Kristen conducts inspections of clinical and preclinical bioanalytical studies, leveraging full scientific knowledge of bioanalytical instruments such as HPLC and LC-MS/MS. In a parallel role as a Pharmacy Specialist at CVS Health since October 2011, Kristen is responsible for scheduling over 50 pharmacists, maintaining metrics for 22 stores, and ensuring training for more than 250 personnel, while also achieving and maintaining excellence status with 97% and above. Previous experience includes a Quality Assurance Auditor I role at Charles River Laboratories, where Kristen audited complex study designs for compliance with GLP regulations, and a Pharmacy Technician position at CVS Pharmacy. Kristen holds a Bachelor of Science in Biochemistry from Albright College, earned in 2006.
This person is not in any offices
Tandem Labs
Tandem Labs (now Covance) is a leading bioanalytical service provider with cutting-edge technology and services focused on supporting small and large-molecule development efforts for discovery, pre-clinical and clinical studies. We strive to differentiate ourselves with our scientific expertise, responsive project management staff, structured method development, on-time metrics, and strong regulatory history. Our goal is to use our experience to make your job easier and to shorten your development timelines. Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading health care diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. Going forward, Tandem Labs and Covance will operate together under the Covance brand. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue in excess of $8 billion in 2013 and more than 48,000 employees in over 60 countries, LabCorp offers innovative solutions to healthcare stakeholders. LabCorp clients include physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs. To learn more about Covance Drug Development, visit www.covance.com.